-
Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis
13 Mar 2025 15:57 GMT
… GPPASI) and the Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) … control; PV, psoriasis vulgaris; GPP, generalized pustular psoriasis.
MMP9 Expression Level … inhibitors in pustular and erythrodermic psoriasis: a retrospective. Multicentre …
-
First-in-class oral immunomodulator shows efficacy in psoriasis models
13 Mar 2025 17:17 GMT
Immune
Psoriasis is a chronic, recurrent and …
-
Homeopathic Remedies For Acne, Eczema, And Psoriasis
13 Mar 2025 11:19 GMT
… acne treatment, eczema and psoriasis in a holistic way. … with sadness and anxiety.
Psoriasis: Treatment Of Chronic Skin … .The homeopathic treatment of psoriasis is determined to resolve … eruptions.
SEPIA: Help at psoriasis, especially in women aggravated by …
-
Johnson & Johnson’s Icotrokinra Succeeds Across Multiple Trials in Moderate-to-Severe Plaque Psoriasis, Ulcerative Colitis
13 Mar 2025 01:09 GMT
… moderate-to-severe plaque psoriasis (PsO) and ulcerative colitis … moderate-to-severe plaque psoriasis are seeking options that … standard of treatment in plaque psoriasis. News release. Johnson … -of-treatment-in-plaque-psoriasis
2. Icotrokinra meets primary …
-
ICONIC-LEAD in Plaque Psoriasis
12 Mar 2025 21:00 GMT
… placebo in patients with plaque psoriasis.
Icotrokinra is a first- … with moderate-to-severe plaque psoriasis were randomized 2:1 … of 0 or 1 and Psoriasis Area and Severity Index ( … with moderate-to-severe plaque psoriasis.”
Medical writing support was provided …
-
A ‘TYK’ Above Placebo: ICP-488 in Plaque Psoriasis
12 Mar 2025 21:00 GMT
… with moderate-to-severe plaque psoriasis compared with placebo at week … improvement from baseline in the Psoriasis Area and Severity Index score … -tolerated oral therapy for plaque psoriasis,” Dr. Zhang concluded. “A high …
-
Positive results showcase icotrokinra’s ‘unique’ mechanism of action in plaque psoriasis
12 Mar 2025 20:37 GMT
… moderate to severe plaque psoriasis, according to a late … of moderate to severe plaque psoriasis, according to Robert Bissonnette, … their moderate to severe plaque psoriasis.
“Its mechanism of … moderate to severe plaque psoriasis were randomly assigned to …
-
Awareness of the Risk of Paradoxical Psoriasis in Patients with SAPHO Syndrome Undergoing Treatment with Secukinumab: A Case Series
12 Mar 2025 16:07 GMT
… Notably, two patients developed paradoxical psoriasis during the course of treatment … experienced significant improvement in paradoxical psoriasis within 12 weeks after discontinuing … highest risk of developing paradoxical psoriasis compared to other biologic …
-
Robert Bissonnette, MD: Late-Breaking Data on Icotrokinra Shows Promising Efficacy and Safety in Psoriasis
12 Mar 2025 15:12 GMT
… up.”
Looking at existing psoriasis treatments were also a … are using to treat psoriasis,” Bissonnette told Dermatology Times … scalp, genital, and palmoplantar psoriasis, as well as psoriatic … ICONIC-ADVANCE for Plaque Psoriasis. Dermatology Times. March 11 …
-
Sex Differences in Psoriasis Impact Perceptions of Disease, Treatment, & Quality of Life
12 Mar 2025 00:58 GMT
… management.
Current guidelines for systemic psoriasis treatment, such as the EuroGuiDerm … underestimate the psychological impact of psoriasis in women. Addressing these … which disproportionately affect women with psoriasis. Expanding access to mental health …
About
© 1995-2025